MicroRNAs: A Novel Non-Invasive Biomarker for Patients with Urological Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|15|5|486-491

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.15, Iss.5, 2014-05, pp. : 486-491

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of microRNAs in the Pathogenesis and Treatment of Hematopoietic Malignancies

By  

Current Pharmaceutical Design, Vol. 19, Iss. 7, 2013-02 ,pp. : 1201-1210

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 5, 2014-05 ,pp. : 475-485

Bentham Science Publishers

Access to resources Recommend Favorite

Bonafide Targets of Deregulated microRNAs in Non-Small Cell Lung Cancer as Tool to Identify Novel Therapeutic Targets: A Review

By  

Current Pharmaceutical Design, Vol. 23, Iss. 1, 2017-02 ,pp. : 55-72

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs: Novel Diagnostic and Prognostic Biomarkers in Atherosclerosis

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 13, 2013-07 ,pp. : 1503-1517

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs: A Novel Therapeutic Target for Schizophrenia

By  

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 176-188

Bentham Science Publishers

Access to resources Recommend Favorite